Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials

DSpace Repository

Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials

Author: Goetz, Matthew P.; Okera, Meena; Wildiers, Hans; Campone, Mario; Grischke, Eva-Maria; Manso, Luis; Andre, Valerie A. M.; Chouaki, Nadia; San Antonio, Belen; Toi, Masakazu; Sledge, George W.
Tübinger Autor(en):
Grischke, Eva-Maria
Published in: Breast Cancer Research and Treatment (2021), Bd. 186, H. 2, S. 417-428
Verlagsangabe: Springer
Language: English
Full text: http://dx.doi.org/10.1007/s10549-020-06029-y
ISSN: 1573-7217
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)